Discounted Cash Flow

U S Physical Therapy Inc. /N.V.

USPH · Based on 10 years of SEC filings

Average annual growth rates

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income

Average annual growth is the mean year-over-year change across each period.

Endpoint CAGR (better for long term trend)

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income

Endpoint CAGR is the compound annual rate from the first to last year in each period.

Projections use average year-over-year growth. Change this in Settings.

Projected growth rate

Free cash flow growth
10-year: — 5-year: — 3-year: —
Averaged growth (FCF & NI)
10-year: — 5-year: — 3-year: —
Net income growth
10-year: — 5-year: — 3-year: —
Sales growth (not added to calculations)
10-year: — 5-year: — 3-year: —

Click a greyed-out slider to switch metrics. Slide between the 10-year, 5-year, and 3-year historic growth rates for FCF, net income, or their average.

%
%

Historical inputs (10 fiscal years)

YEAR Sales Net Income Free Cash Flow Net Margin EPS (diluted)
2016 $356.5m $20.6m $51.0m 5.8% $0.68
2017 $414.1m (16.1%) $22.3m (8.3%) $56.5m (10.7%) 5.4% (-6.7%) $0.80 (17.6%)
2018 $453.9m (9.6%) $34.9m (56.7%) $73.0m (29.2%) 7.7% (42.9%) $0.92 (15.0%)
2019 $482.0m (6.2%) $40.0m (14.8%) $62.4m (-14.5%) 8.3% (8.1%) $1.14 (23.9%)
2020 $423.0m (-12.2%) $35.2m (-12.1%) $100.0m (60.1%) 8.3% (0.2%) $0.32 (-71.9%)
2021 $495.0m (17.0%) $40.8m (16.0%) $76.4m (-23.6%) 8.2% (-0.9%) $2.41 (653.1%)
2022 $553.1m (11.7%) $32.2m (-21.2%) $50.3m (-34.2%) 5.8% (-29.5%) $2.25 (-6.6%)
2023 $604.8m (9.3%) $28.2m (-12.2%) $72.7m (44.5%) 4.7% (-19.7%) $1.28 (-43.1%)
2024 $671.3m (11.0%) $31.4m (11.3%) $65.8m (-9.5%) 4.7% (0.2%) $1.84 (43.8%)
2025 $781.0m (16.3%) $39.6m (26.0%) $61.0m (-7.2%) 5.1% (8.3%) $1.42 (-22.8%)

Base FCF: (latest fiscal year)

Discount rate: %

Terminal growth:

Projection period: years

Alt A decline yrs:

Alt B total yrs:

Projected cash flows

Year Projected cash flow Discount Factor Present Value

PV of projected FCF:

Terminal FCF:

Terminal value:

PV of terminal value:

Enterprise value (DCF):

DCF price per share:

Current price:

Alternative DCF Models

Model Fair Value Upside PV(FCFs) PV(Terminal) Total Years
Standard (10yr→TV) 10 + TV
Alt A (Gradual Decline)
Alt B (30yr Hard Stop) N/A

This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.

+ 10YR Financials Balance Sheet (10YR) Cash Flow (10YR) DCF Model